REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hainan Huluwa Pharmaceutical Group Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hainan Huluwa Pharmaceutical Group Co., Ltd. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hainan Huluwa Pharmaceutical Group Co., Ltd. is focused on the R&D, production and sales of children's drugs. The company provides drugs for the treatment of respiratory and digestive diseases in children. The company was established in 2005, headquartered in Haikou City, China.

Headquarters
No. 30, Anyu 1st Road, Xiuying District, Haikou City, Hainan Province
Haikou; Hainan; Postal Code: 570311

Contact Details: Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. report to view the information.

Website: http://www.huluwayaoye.com

Basic Information
Total Employees:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hainan Huluwa Pharmaceutical Group Co., Ltd. report to view the information.
Incorporation Date:
June 22, 2005
Key Executives
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
41.76%
Purchase this report to view the information.
14.38%
Purchase this report to view the information.
8.21%
Purchase this report to view the information.
4.89%
Purchase this report to view the information.
4.7%
Subsidiaries
Chengde Xin Aimin Pharmaceutical Co., Ltd.
100%
Guangxi Laibin Huluwa Pharmaceutical Co., Ltd.
100%
Guangxi Weiwei Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hainan Huluwa Pharmaceutical Group Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.59%▼
Total operating revenue
-5.36%▼
Operating profit (EBIT)
-7.86%▼
Net Profit (Loss) for the Period
6.42%▲
Total assets
17.22%▲
Total equity
5.73%▲
Operating Profit Margin (ROS)
-0.12%▼
Net Profit Margin
0.9%▲
Return on Equity (ROE)
0.05%▲
Debt to Equity Ratio
-6.87%▼
Quick Ratio
-0.61%▼
Cash Ratio
-0.15%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Sinocelltech Group Limited
 
Jiangxi Tianxin Pharmaceutical Co., Ltd.
Zai Lab Limited (Hong Kong) (再鼎医药有限公司 (香港))
 
Sihuan Pharmaceutical Holdings Group Limited
Changchun Bcht Biotechnology Co.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo